InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
T+90 hit rate
44%
T+90 mean return
+4.3%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Gheuens Sarah, Directeur Médical. Insider active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. Aggregated, 42 reports have been logged. Split: 0 buy · 11 sells. Total volume traded: €442k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 2 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations42 total
8,375 sharesCommon stockSEC:0001439222-26-000110:0
4,007 sharesCommon stockSEC:0001439222-26-000110:1
8,500 shares0Common stockSEC:0001439222-26-000065:0
2,940 shares@ US$34.71100.0% of flowCommon stockSEC:0001439222-26-000065:1
4,000 shares0Common stockSEC:0001439222-26-000040:0
1,187 shares@ US$28.967.7% of flowCommon stockSEC:0001439222-26-000040:1
5,666 shares0Common stockSEC:0001439222-26-000040:2
1,681 shares@ US$28.9610.9% of flowCommon stockSEC:0001439222-26-000040:3
4,000 shares0Common stockSEC:0001439222-26-000040:4
1,187 shares@ US$28.967.7% of flowCommon stockSEC:0001439222-26-000040:5
6,000 shares0Common stockSEC:0001439222-26-000006:0
2,454 shares@ US$25.017.0% of flowCommon stockSEC:0001439222-25-000118:0
200 shares@ US$25.010.6% of flowCommon stockSEC:0001881190-25-000004:0
3,302 shares@ US$25.0110.1% of flowCommon stockSEC:0001439222-25-000111:0
11,914 shares@ US$25.0140.0% of flowCommon stockSEC:0001439222-25-000082:0
8,374 shares0Common stockSEC:0001439222-25-000073:0
6,000 shares0Common stockSEC:0001439222-25-000069:0
3,833 shares0Common stockSEC:0001439222-25-000013:0
1,137 shares@ US$35.5410.2% of flowCommon stockSEC:0001439222-25-000013:1
4,000 shares0Common stockSEC:0001439222-25-000013:2
1,187 shares@ US$35.5410.7% of flowCommon stockSEC:0001439222-25-000013:3
5,667 shares0Common stockSEC:0001439222-25-000013:4
1,681 shares@ US$35.5415.1% of flowCommon stockSEC:0001439222-25-000013:5
8,375 shares0Common stockSEC:0001439222-24-000111:0
3,834 shares0Common stockSEC:0001439222-24-000054:0
25 of 42 declarations
About Gheuens Sarah
Gheuens Sarah serves as Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. In this role, she oversees medical operations and contributes to the company's research and development strategy. With extensive experience in the pharmaceutical sector, she is committed to promoting innovation and excellence in healthcare.
